Shire submits investigational New Drug Application to FDA for Gene … – GlobeNewswire (press release)
|
Shire submits investigational New Drug Application to FDA for Gene …
GlobeNewswire (press release) Lexington, Mass. – July 6, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving people with rare diseases, … Shire Submits Application To US FDA For Gene Therapy For Hemophilia BRIEF-Shire submits IND application for gene therapy candidate SHP654 |
